Anthony G. Mansour
Immunology and Microbiology · The Ohio State University
Publications
104
Citations
1,387
Est. group size
~2
Recurring co-author estimate
Active years
15
Publishing since 2012
Anthony G. Mansour's work focuses on immunology and cancer treatment, particularly engineering immune cells such as natural killer (NK) cells to fight cancers like non-small cell lung cancer. His publications also touch on genomic markers that predict how tumors like mesothelioma respond to chemotherapy and immunotherapy, as well as clinical outcomes for blood cancer treatments and side effects of cancer immunotherapies.
Publication output has grown over the past decade, rising from about 5 papers per year in 2017-2018 to a peak of 22 in 2024, though with some year-to-year fluctuation.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Supplementary Figure S2 from Preclinical Evaluation of Off-The-Shelf PD-L1<sup>+</sup> Human Natural Killer Cells Secreting IL15 to Treat Non–Small Cell Lung Cancer
2026
- Supplementary Figure S1 from Preclinical Evaluation of Off-The-Shelf PD-L1<sup>+</sup> Human Natural Killer Cells Secreting IL15 to Treat Non–Small Cell Lung Cancer
2026
- Supplementary Figure S5 from Preclinical Evaluation of Off-The-Shelf PD-L1<sup>+</sup> Human Natural Killer Cells Secreting IL15 to Treat Non–Small Cell Lung Cancer
2026
- Supplementary Figure S6 from Preclinical Evaluation of Off-The-Shelf PD-L1<sup>+</sup> Human Natural Killer Cells Secreting IL15 to Treat Non–Small Cell Lung Cancer
2026
- Supplementary Figure S3 from Preclinical Evaluation of Off-The-Shelf PD-L1<sup>+</sup> Human Natural Killer Cells Secreting IL15 to Treat Non–Small Cell Lung Cancer
2026
- Supplementary Figure S4 from Preclinical Evaluation of Off-The-Shelf PD-L1<sup>+</sup> Human Natural Killer Cells Secreting IL15 to Treat Non–Small Cell Lung Cancer
2026
- PP01.31: Genomic Predictors of Response to Platinum-Based Chemotherapy and Immunotherapy in Malignant Pleural Mesothelioma
Journal of Thoracic Oncology · 2026
- A community outreach program enhances education on opioid and e-cigarette misuse among teenagers
Frontiers in Public Health · 2025
- An atypical presentation of immune checkpoint inhibitor associated myositis with normal creatine kinase: a case report
Frontiers in Immunology · 2025
- Preclinical Evaluation of Off-The-Shelf PD-L1+ Human Natural Killer Cells Secreting IL15 to Treat Non–Small Cell Lung Cancer
Cancer Immunology Research · 2024
- Outcomes of Patients with Chronic Lymphocytic Leukemia Discontinuing Bruton Tyrosine Kinase Inhibitors Due to Adverse Effects
Blood · 2024
- Supplementary Figure S2 from Preclinical Evaluation of Off-The-Shelf PD-L1<sup>+</sup> Human Natural Killer Cells Secreting IL15 to Treat Non–Small Cell Lung Cancer
2024
- Supplementary Figure S4 from Preclinical Evaluation of Off-The-Shelf PD-L1<sup>+</sup> Human Natural Killer Cells Secreting IL15 to Treat Non–Small Cell Lung Cancer
2024
- Supplementary Figure S6 from Preclinical Evaluation of Off-The-Shelf PD-L1<sup>+</sup> Human Natural Killer Cells Secreting IL15 to Treat Non–Small Cell Lung Cancer
2024
- Supplementary Figure S6 from Preclinical Evaluation of Off-The-Shelf PD-L1<sup>+</sup> Human Natural Killer Cells Secreting IL15 to Treat Non–Small Cell Lung Cancer
2024
- Figshare×10
- Cancer Research×6
- Blood×5
- JCI Insight×2
- Brain Behavior and Immunity×2
- Alexander L. Dent
Immunology and Microbiology · Indiana University
- Yiping Yang
Immunology and Microbiology · The Ohio State University
- Xiaopei Huang
Immunology and Microbiology · The Ohio State University
- Jianhua Yu
Immunology and Microbiology · The Ohio State University
- Ankita Saini
Immunology and Microbiology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile